CommercialCoverageLow impact
08.01.74b, Lumasiran (Oxlumo®)
Independence Blue Cross·Nephrology, Pediatrics·Pharmacy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Policy 08.01.74b regarding Lumasiran (Oxlumo®) pharmacy coverage has been updated for commercial plans. This is a fresh policy change that will take effect October 1, 2025, affecting billing and coverage for this rare disease medication.
Action Required
By October 1, 2025: Billing team should review the updated Lumasiran (Oxlumo®) policy at the provided URL to understand any changes to coverage criteria, prior authorization requirements, or billing procedures for this specialty pharmacy medication. Verify current protocols align with new policy requirements.